期刊文献+

环孢霉素A在服药患者尿液中的含量测定

Concentration of cyclosporine A in urine of patients taking CsA
下载PDF
导出
摘要 目的了解环孢霉素A在服药患者尿液中的含量。方法检测20例肾移植患者CsA全血谷值浓度和尿液中CsA浓度。结果 20例肾移植患者CsA全血谷值浓度为(73.46±15.54)μg·L-1,尿液CsA浓度为(174.83±101.52)μg·L-1。结论CsA可以通过尿液途径部分排出体外。 Objective To explore the concentration of Cyclosporine A in urine of patients taking CsA. Methods We detected CsA in whole blood and urine of 20 renal transplant recipients after taking CsA 12h. Results CsA in whole blood and urine of 20 renal transplant recipients were (73.46 ± 15.54)μg·L-1 and (174.83 ± 101.52)μg·L-1 respectively. Conclusion CsA can be excreted in part by urine.
出处 《安徽医药》 CAS 2014年第1期132-133,共2页 Anhui Medical and Pharmaceutical Journal
关键词 环孢霉素A浓度 全血 尿液 concentration of CsA whole blood urine
  • 相关文献

参考文献5

  • 1Cmstens J. Three year experience with Neolal C2 monitoling adjus ted to a talgeet lange of 500-600 ng/ml in long telm lenal hans plant lecipienm leceiving dual immunosupplessive thelxpy [ J] Stand J U ld Nephrol,2008,42 (3) :286-292.
  • 2黄君龄,王祥慧,潘隽玮,郭庆,徐达,周佩军,邵琨.肾移植患者应用微乳化环孢素后监测血药谷浓度、峰浓度的临床价值比较[J].器官移植,2011,2(3):157-161. 被引量:4
  • 3Holt DW,Johnstn A, Roberts NB, et al. Methodological and clinical aspects of cyclosporin monitoring :report of the association of clinical biochemists task force [J].Ann Clin Biochem,1994,31:420-446.
  • 4Oellelich M,Armsuong VW,Kahan B,et al. Lake Louise consen sus confelence on cyclospolin monitoling in olgan tlansplantation: leport of the concensus panel[J]. The1 Drag Monit,1995,17(6) :642-654.
  • 5叶卫东,王雪,刘巧玲.环孢霉素A在服药患者血浆中的分布[J].安徽医药,2012,16(11):1653-1654. 被引量:3

二级参考文献18

  • 1Hesselink DA,van Dam T,Metselaar HJ,et al.The relative importance of cyclosporine exposure in heart,kidney or liver transplant recipients on maintenance therapy[J].Transpl Int,2004,17(9):495-504.
  • 2International Neoral Renal Transplantation Study Group.Cyclosporine microemulsion(neoral)absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation[J].Am J Transplant,2002,2(2):148-156.
  • 3Stoves J,Baker R,Newstead CG.Measurement of cyclosporin exposure in renal transplant recipients during the early post-operative period:is C2 alone sufficient?[J] Nephrol Dial Transplant,2005,20(4):854-855.
  • 4Karamperis N,Koefoed-Nielsen P,Bagger Srensen A,et al.Role of metabolites and calcineurin inhibition on C2 monitoring in renal transplant patients[J].Nephrol Dial Transplant,2005,20(3):618-621.
  • 5Arwa YA,Noorizan AA,Yahaya H,et al.Therapeutic monitoring of cyclosporine in renal transplant patients[J].Int J Pharmacy Pharm Sci,2010,2(Suppl 4):224-226.
  • 6Keown P,Kahan BD,Johnston A,et al.Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies:report from the International Neoral TDM Advisory Consensus Meeting(Vancouver,November 1997)[J].Transplant Proc,1998,30(5):1645-1649.
  • 7Mahalati K,Belitsky P,West K,et al.Approaching the therapeutic window for cyclosporine in kidney transplantation:a prospective study[J].J Am Soc Nephrol,2001,12(4):828-833.
  • 8Cantarovich M,Ross H,Arizón JM,et al.Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction[J].Transplantation,2008,85(7):992-999.
  • 9Carstens J.Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy[J].Scand J Urol Nephrol,2008,42(3):286-292.
  • 10Halloran P.Calcineurin inhibition-relationship to cyclosporin blood concentration[M] // Halloran P,Johnston A,Kahan BD,et al.Focus on Medicine.13rd ed.Oxford:Blackwell Science,1998:15-18.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部